Articles related to RISK ASSESSMENT

Prostate cancer screening guidelines that use race as a criterion are under ethical scrutiny, with experts calling for a shift towards universal, unbiased risk assessment that addresses socioeconomic factors and healthcare access disparities.

Infrequent soft stools were associated with higher risks of all-cause, cancer, and cardiovascular disease mortality, suggesting that stool monitoring could be a valuable indicator of major chronic illnesses.

Recent findings indicate that statin-naïve ACS patients with normal LDL-C levels at admission may face worse outcomes, challenging current perspectives on lipid management in cardiovascular care.

Statins remain a cornerstone of cardiovascular disease prevention, but managing potential side effects is key to ensuring patient adherence and optimal outcomes. This article provides a comprehensive overview of statin-associated adverse effects and practical management strategies for clinicians.

A comprehensive study spanning over two decades has found no evidence that daily multivitamin use reduces the risk of death from any cause, including cancer and cardiovascular disease.

The introduction of the PREVENT equations could reduce the number of adults eligible for statin therapy by nearly 40%, impacting clinical guidelines and patient care strategies.